These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 949564

  • 21. A new batch method of preparing intravenous piggyback solutions in polyvinylchloride containers.
    Levy R, Kleinberg M, Lee P.
    Hosp Pharm; 1980 Oct; 15(10):504-6. PubMed ID: 10309298
    [Abstract] [Full Text] [Related]

  • 22. Parenteral development of clindamycin-2-phosphate.
    Riebe KW, Oesterling TO.
    Bull Parenter Drug Assoc; 1972 Oct; 26(3):139-46. PubMed ID: 5035118
    [No Abstract] [Full Text] [Related]

  • 23. Bulk compounding technology.
    Am J Hosp Pharm; 1968 Jun; 25(6):320. PubMed ID: 5656779
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous therapy. 6. Compatibilities of drug additives.
    Williams JT, Moravec DF.
    Hosp Manage; 1966 Jun; 101(6):43-4. PubMed ID: 5932207
    [No Abstract] [Full Text] [Related]

  • 25. Drug additive compatibility--a manufacturer's concern.
    Nedich RL.
    Bull Parenter Drug Assoc; 1973 Jun; 27(5):228-33. PubMed ID: 4201030
    [No Abstract] [Full Text] [Related]

  • 26. Particulate matter in parenteral solutions.
    Med Lett Drugs Ther; 1968 May 31; 10(11):42-4. PubMed ID: 5656614
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Intravenous admixture incompatibility.
    Donn R.
    Am J Nurs; 1971 Feb 31; 71(2):325. PubMed ID: 5203610
    [No Abstract] [Full Text] [Related]

  • 30. [Deterioration of parenterals due to compounding].
    Kyakui N.
    Kango Gijutsu; 1970 Feb 31; ():67-74. PubMed ID: 5199396
    [No Abstract] [Full Text] [Related]

  • 31. Guidelines for phenytoin infusions.
    Tuttle CB.
    Can J Hosp Pharm; 1984 Feb 31; 37(4):137-9. PubMed ID: 10269318
    [Abstract] [Full Text] [Related]

  • 32. Pyrogens in small-volume parenterals prepared in hospital pharmacy.
    Lacasa C, Vega FA.
    J Parenter Sci Technol; 1989 Feb 31; 43(5):246-9. PubMed ID: 2809933
    [Abstract] [Full Text] [Related]

  • 33. Mixing additives in plastic LVPs.
    Deardorff DL, Schmidt CN.
    Am J Hosp Pharm; 1980 Dec 31; 37(12):1610, 1613. PubMed ID: 7446534
    [No Abstract] [Full Text] [Related]

  • 34. Intravenous therapy. 7. Admixtures of drugs.
    Williams JT, Moravec DF.
    Hosp Manage; 1966 Jul 31; 102(1):61-2. PubMed ID: 5938724
    [No Abstract] [Full Text] [Related]

  • 35. I. V. additive program belongs in the pharmacy.
    Brown RG.
    Hospitals; 1969 Sep 16; 43(18):92-8. PubMed ID: 5809375
    [No Abstract] [Full Text] [Related]

  • 36. [Quality control of infusion solutions. I. Foreign particles in infusion solutions].
    van den Bemd AA.
    Pharm Weekbl; 1969 Sep 26; 104(39):1205-9. PubMed ID: 5345140
    [No Abstract] [Full Text] [Related]

  • 37. Drug incompatibility from the standpoint of the intravenous route of drug administration.
    Williams JT.
    Hosp Manage; 1968 Jan 26; 105(1):38 passim. PubMed ID: 5634868
    [No Abstract] [Full Text] [Related]

  • 38. The right solution: mixing I.V. drugs thoroughly.
    Motz-Harding E, Good F.
    Nursing; 1985 Feb 26; 15(2):62-4. PubMed ID: 3844125
    [No Abstract] [Full Text] [Related]

  • 39. Design for a small-volume parenteral manufacturing facility.
    Anisfeld MH, Lovejoy CK.
    J Parenter Drug Assoc; 1978 Feb 26; 32(6):285-90. PubMed ID: 251575
    [No Abstract] [Full Text] [Related]

  • 40. I.V. additives move to the pharmacy.
    Peritore SP, Rosenberg JM.
    Hospitals; 1971 Dec 16; 45(24):84-91. PubMed ID: 5135288
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.